Transient ischemic attack (TIA), commonly known as a mini-stroke,
is a condition in which the blood supply to part of the brain is briefly
interrupted by a clot or narrowed blood vessel and temporarily stops bleeding
flow. This cuts off oxygen and nutrients, causing temporary symptoms. Some
common symptoms of TIA include sudden weakness or numbness on one side of the
body; sudden blurred, or loss of vision in one or both eyes; sudden confusion
or trouble speaking or understanding speech; sudden trouble walking or loss of
balance or coordination; and sudden severe headache. TIA is a warning sign and
signal of a possible upcoming stroke. The detection and treatment of TIA helps
to prevent long term disability from stroke. The global transient ischemic
attack market offers devices and drugs to diagnose and treat TIA. MRI systems,
CT scanners and ultrasound devices are widely used for TIA diagnosis. Drugs
used for Transient Ischemic Attack Market treatment includes antiplatelets such
as aspirin, dipyridamole and clopidogrel.
compound annual growth rate (CAGR) of 6.2% from 2024 to
2031.
Stryker, Boston Scientific, Cordis Corporation, Abbott Laboratories, and GE
Healthcare.
disorders are driving the demand for Transient
Ischemic Attack Market treatment. According to World Health
Organization, the population aged above 60 years is growing at a rate of 3%
every year globally. Elderly people are more prone to develop TIA.
developing regions of Asia Pacific, Latin America, and Middle East & Africa
to tap the potential opportunities. The increasing healthcare investments by
governments and improving reimbursement scenario in developing countries will
support the TIA market growth.
attack market. As per United Nations data, the world’s population aged 60 years
and above is projected to double from 962 million in 2017 to 2.1 billion in
2050. The risk of TIA increases with age. Additionally, sedentary lifestyle,
lack of physical activity, obesity and hypertension are risk factors highly
prevalent in geriatric population which further drives their vulnerability to
TIA. Therefore, rapidly expanding pool of aged population will continue to
provide a large patient base requiring diagnosis and treatment through the
forecast period. Growing prevalence of cardiovascular diseases and neurological
disorders are also significantly fueling the demand for TIA management.
Transient Ischemic Attack market. Russia’s invasion of Ukraine and subsequent
Western sanctions have caused severe global economic disruption. As inflation
soars and economies struggle, healthcare budgets are coming under severe
pressure. This is affecting the ability of consumers and providers to invest in
advanced treatment options for conditions like Transient Ischemic Attack.
Manufacturers are also facing shortages and price increases in vital raw
materials due to supply chain issues. The conflict is exacerbating an already
difficult post-pandemic recovery for the medical devices industry.
and look beyond traditional markets. Greater cooperation and capacity building
is needed in developing regions to make therapies affordable and accessible to
more patients worldwide. Technology transfer partnerships can help build local
production hubs. Governments and aid agencies must support under-served rural
populations with preventive care and awareness programs. Telehealth and mHealth
solutions can help bridge geographic divides. Overall, a multipronged global
strategy of stabilising economies, expanding access to financing, and
strengthening public health systems will be vital to sustain gains against
Transient Ischemic Attack in this turbulent geopolitical climate.
terms of value is currently highest in North America and Western Europe.
Developed healthcare systems and greater awareness among aging populations have
propelled market growth in these regions. However, Asia Pacific is emerging as
the fastest growing regional market. Rising incomes, increasing medical
tourism, greater penetration of private insurance and expanding healthcare
infrastructure are driving increased spending on treatment and diagnosis of
conditions like Transient Ischemic Attack across major Asian economies. China
and India in particular have huge untapped market potential and are predicted
to become major future global centers. Aggressive awareness campaigns tailored
for local needs will be important to sustain this momentum.
Get more insights on : Transient
Ischemic Attack Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold
in the market research industry. She specializes in writing well-researched
articles from different industries, including food and beverages, information
and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
